Crossroads Treatment Center is categorized under Family Practice Doctors in Greenville, SC and active since 2011.
Crossroads Treatment Center was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact David J Bolton at the company’s single location by writing to 33 Market Point Drive, Greenville, South Carolina SC 29607 or by phoning (864) 288-7636. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Crossroads Treatment Center |
Contact Person: | David J Bolton |
Address: | 33 Market Point Drive, Greenville, South Carolina 29607 |
Phone Number: | (864) 288-7636 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Family Practice Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Crossroads Treatment Center was started in 2011 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact David J Bolton for inquiries that concern Crossroads Treatment Center by calling the company number (864) 288-7636, as your correspondence is most welcome. Additionally, the physical location of the single location of Crossroads Treatment Center can be found at the coordinates 34.822366,-82.302118 as well as the street address 33 Market Point Drive in Greenville, South Carolina 29607.
For its online presence, you may visit Crossroads Treatment Center’s website at and engage with its social media outlets through on Twitter and on Facebook.